Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Hodgkin Disease 3Breast Neoplasms 3Lymphoma, Non-Hodgkin 2Leukemia 2Triple Negative Breast Neoplasms 1Teratoma 1Rhabdomyosarcoma 1Renal Pelvis and Ureter Urothelial Carcinoma 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pain 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, AIDS-Related 1Lymphoma 1Inflammatory Breast Neoplasms 1Infiltrating Bladder Urothelial Carcinoma 1Glioma 1Choriocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Embryonal 1Burkitt Lymphoma 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 13Vincristine 10Etoposide 8Methotrexate 7Doxorubicin 7Dexamethasone 7Cytarabine 7venetoclax 6Calcium Dobesilate 6merphos 5dexamethasone acetate 5dexamethasone 21-phosphate 5calaspargase pegol 5auricularum 5Specimen Handling 5Prednisone 5prednylidene 4pegaspargase 4deltacortene 4Thioguanine 4Mercaptopurine 4Magnetic Resonance Spectroscopy 4Leucovorin 4Granulocyte Colony-Stimulating Factor 4Daunorubicin 4Asparaginase 4fludarabine phosphate 3daratumumab 3azathiopurine 3Rituximab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × pegfilgrastim × 90 days × Clear all
NCT06738368 2026-05-12

Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia

University of Washington

Phase 2 Recruiting
30 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡